On October 27, 2009
Wall Street: “500 Axed AstraZeneca Reps Are Worth Only 5 Cents”
Analysts at Leerink Swann believe that AstraZeneca could add 5 cents in earnings per share for every 500 pharmaceutical sales reps that it fires.
0 Comments